ICU Medical Inc

IC7

Company Profile

  • Business description

    ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

  • Contact

    951 Calle Amanecer
    San ClementeCA92673
    USA

    T: +1 949 366-2183

    E: [email protected]

    https://www.icumed.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    31 December 2025

    Employees

    14,000

Stocks News & Analysis

stocks

Competition impacting ASX market darling

Shares tumble after results.
stocks

Ask the analyst: Is the market underestimating Bapcor?

This moated ASX company's shares are in a prolonged slump. I quizzed our analyst Angus Hewitt on its management, the potential impact of EVs, and more.
stocks

Is our ASX best idea still attractive after shares surge?

Shares rose over 21% following the results. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,752.504.900.06%
CAC 408,006.2233.190.42%
DAX 4021,911.74124.740.57%
Dow JONES (US)44,470.41167.010.38%
FTSE 1008,767.8067.270.77%
HKSE21,395.73126.25-0.59%
NASDAQ19,714.27190.870.98%
Nikkei 22538,801.1714.150.04%
NZX 50 Index12,917.4541.100.32%
S&P 5006,066.4440.450.67%
S&P/ASX 2008,485.002.200.03%
SSE Composite Index3,316.835.34-0.16%

Market Movers